[ET Net News Agency, 3 August 2021] WUXI BIO (02269) rose 3.39% to HK$125.2, breaking
above the 10-D SMA of HK$122.87.
It hits an intra-day high of HK$125.2, and an intra-day low of HK$119.1. The total
shares traded was 3.27 million, with a value of HK$398.9m. The active buy/sell ratio is
63:37, with net buying turnover of HK$92.32m. CLSA LTD accounts for greatest net
responsive buying turnover of HK$18.33m, with volume weighted average price of HK$122.328.
HSBC SEC BRO (ASIA) accounts for greatest net responsive selling turnover of HK$27.05m,
with volume weighted average price of HK$122.338. The stock has risen a combined 5.65%
over the past 2 consecutive trading days.
The Hang Seng Index now fell 275 points, or 1.05% to 25,960; the Hang Seng China
Enterprises Index now fell 103 points, or 1.1% to 9,233; the Hang Seng TECH Index now fell
132 points, or 1.95% to 6,663; with an overall turnover of HK$57.16b.
The SSE Composite Index now fell 14 points, or 0.41% to 3,450, with an overall turnover
of RMB198.02b.
The SZSE Component Index now fell 60 points, or 0.41% to 14,737, with an overall
turnover of RMB141.48b.
Basic Information
-------------------------------------------
Nominal 125.200 % Chg +3.39%
High 125.200 Low 119.100
Shares Tr 3.27m Turnover 398.9m
10-D SMA 122.870 %H.V 85.646
20-D SMA 129.370 VWAP 122.021
50-D SMA 128.104 RSI14 48.256
-------------------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 63:37, with net buying
turnover of HK$92.32m, rising a combined 5.65% over the past 2 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
WUXI BIO (02269) 125.20 +3.39
HUTCHMED (00013) 68.25 +1.41
GENSCRIPT BIO (01548) 36.55 +4.88
INNOVENT BIO (01801) 80.75 +2.22
JUNSHI BIO (01877) 55.50 +6.02
JXR (01951) 14.30 +0.28
CSTONE PHARMA-B (02616) 15.50 +10.71
BEIGENE (06160) 198.60 +3.22
CANSINOBIO-B (06185) 362.00 +7.42
KINTOR PHARMA-B (09939) 81.20 +4.10
-------------------------------------------------
(ed)